Announcement, From Bench to Fireside 03.27.24 Share on Twitter Share on Facebook Share on LinkedIn From Pediatric Cancer Challenges to CAR T Cell Signaling with Robbie Majzner, MD In this episode, Robbie Majzner, MD, a PICI Investigator at the Dana-Farber Cancer Institute, sits down with PICI Chief Scientific Officer John Connolly, PhD, to discuss efforts to engineer next-generation CAR T cells using synthetic biology to enhance the therapeutic potential for fatal pediatric cancers. Formerly a researcher at Stanford University, where he was mentored by Crystal Mackall, MD, Center Director for the PICI Center at Stanford Medicine, Robbie is among the founding members of Cargo Therapeutics, a PICI investment company. Listen as Robbie covers collaboration in the pediatric oncology field, the distinct characteristics of pediatric cancers and their immuno-biology versus adult cancers, and drug development obstacles for children. Get ready to go from bench to fireside with Robbie Majzner, MD. Listen on Spotify Related Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators Announcement Behind the Breakthrough: An Interview with Carl June, the Father of CAR T-Cell Therapy
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators